A citation-based method for searching scientific literature

Meran Keshawa Ediriweera, Kamani Hemamala Tennekoon, Sameera Ranganath Samarakoon. Semin Cancer Biol 2019
Times Cited: 212







List of co-cited articles
239 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
14


Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review.
Ricardo L B Costa, Hyo Sook Han, William J Gradishar. Breast Cancer Res Treat 2018
222
9

Ovarian cancer statistics, 2018.
Lindsey A Torre, Britton Trabert, Carol E DeSantis, Kimberly D Miller, Goli Samimi, Carolyn D Runowicz, Mia M Gaudet, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2018
9

PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects.
Daniela Miricescu, Alexandra Totan, Iulia-Ioana Stanescu-Spinu, Silviu Constantin Badoiu, Constantin Stefani, Maria Greabu. Int J Mol Sci 2020
121
8

clusterProfiler: an R package for comparing biological themes among gene clusters.
Guangchuang Yu, Li-Gen Wang, Yanyan Han, Qing-Yu He. OMICS 2012
7

Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer.
Tzu-Ting Huang, Erika J Lampert, Cynthia Coots, Jung-Min Lee. Cancer Treat Rev 2020
53
13

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
6

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
6

Targeting PI3K in cancer: mechanisms and advances in clinical trials.
Jing Yang, Ji Nie, Xuelei Ma, Yuquan Wei, Yong Peng, Xiawei Wei. Mol Cancer 2019
577
6


Epithelial ovarian cancer: Evolution of management in the era of precision medicine.
Stephanie Lheureux, Marsela Braunstein, Amit M Oza. CA Cancer J Clin 2019
496
6

The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling.
Boris Y Shorning, Manisha S Dass, Matthew J Smalley, Helen B Pearson. Int J Mol Sci 2020
160
6

Epithelial ovarian cancer.
Stephanie Lheureux, Charlie Gourley, Ignace Vergote, Amit M Oza. Lancet 2019
641
6

PI3k/AKT signaling pathway: Erythropoiesis and beyond.
Mahjoobeh Jafari, Elham Ghadami, Tahereh Dadkhah, Haleh Akhavan-Niaki. J Cell Physiol 2019
104
6

PI3K/Akt signalling pathway and cancer.
Juan Angel Fresno Vara, Enrique Casado, Javier de Castro, Paloma Cejas, Cristóbal Belda-Iniesta, Manuel González-Barón. Cancer Treat Rev 2004
5


PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review).
Youbang Xie, Xuefeng Shi, Kuo Sheng, Guoxiong Han, Wenqian Li, Qiangqiang Zhao, Baili Jiang, Jianming Feng, Jianping Li, Yuhai Gu. Mol Med Rep 2019
172
5

The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a narrative review.
K Sun, J Luo, J Guo, X Yao, X Jing, F Guo. Osteoarthritis Cartilage 2020
124
5

PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers.
Rui Liu, Youwen Chen, Guangzhi Liu, Chenxi Li, Yurong Song, Zhiwen Cao, Wen Li, Jinghong Hu, Cheng Lu, Yuanyan Liu. Cell Death Dis 2020
193
4

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.
Zefang Tang, Chenwei Li, Boxi Kang, Ge Gao, Cheng Li, Zemin Zhang. Nucleic Acids Res 2017
4

Cancer Statistics, 2021.
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
4

The Wnt/β-catenin pathway in ovarian cancer: a review.
Rebecca C Arend, Angelina I Londoño-Joshi, J Michael Straughn, Donald J Buchsbaum. Gynecol Oncol 2013
324
4

Treatment of epithelial ovarian cancer.
Lindsay Kuroki, Saketh R Guntupalli. BMJ 2020
168
4

The PI3K/Akt/mTOR pathway in ovarian cancer: therapeutic opportunities and challenges.
Bianca Cheaib, Aurélie Auguste, Alexandra Leary. Chin J Cancer 2015
136
4

Oncogenic Roles of the PI3K/AKT/mTOR Axis.
Masahiro Aoki, Teruaki Fujishita. Curr Top Microbiol Immunol 2017
192
4

PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond.
Sadegh Fattahi, Fatemeh Amjadi-Moheb, Reza Tabaripour, Gholam Hossein Ashrafi, Haleh Akhavan-Niaki. Life Sci 2020
85
4


The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells.
Ina Nepstad, Kimberley Joanne Hatfield, Ida Sofie Grønningsæter, Håkon Reikvam. Int J Mol Sci 2020
86
4

Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinoma.
Farzad Rahmani, Aghigh Ziaeemehr, Soodabeh Shahidsales, Masoumeh Gharib, Majid Khazaei, Gordon A Ferns, Mikhail Ryzhikov, Amir Avan, Seyed M Hassanian. J Cell Physiol 2020
46
8

The PTEN⁻PI3K Axis in Cancer.
Antonella Papa, Pier Paolo Pandolfi. Biomolecules 2019
116
4

PI3K/AKT/mTOR signaling as a molecular target in head and neck cancer.
Franziska E Marquard, Manfred Jücker. Biochem Pharmacol 2020
109
4

The PI3K Pathway in Human Disease.
David A Fruman, Honyin Chiu, Benjamin D Hopkins, Shubha Bagrodia, Lewis C Cantley, Robert T Abraham. Cell 2017
4

WGCNA: an R package for weighted correlation network analysis.
Peter Langfelder, Steve Horvath. BMC Bioinformatics 2008
3

The MAPK pathway across different malignancies: a new perspective.
Mauricio Burotto, Victoria L Chiou, Jung-Min Lee, Elise C Kohn. Cancer 2014
545
3


Emerging role of PI3K/AKT in tumor-related epigenetic regulation.
Qi Yang, Wei Jiang, Peng Hou. Semin Cancer Biol 2019
75
4

STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets.
Damian Szklarczyk, Annika L Gable, David Lyon, Alexander Junge, Stefan Wyder, Jaime Huerta-Cepas, Milan Simonovic, Nadezhda T Doncheva, John H Morris, Peer Bork,[...]. Nucleic Acids Res 2019
3

PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment.
Angel Guerrero-Zotano, Ingrid A Mayer, Carlos L Arteaga. Cancer Metastasis Rev 2016
222
3

Targeting PI3K/Akt/mTOR Signaling in Cancer.
Camillo Porta, Chiara Paglino, Alessandra Mosca. Front Oncol 2014
878
3

Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy.
Zhenru Xu, Xu Han, Daming Ou, Ting Liu, Zunxiong Li, Guanmin Jiang, Jing Liu, Ji Zhang. Appl Microbiol Biotechnol 2020
196
3

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.
Jianjiong Gao, Bülent Arman Aksoy, Ugur Dogrusoz, Gideon Dresdner, Benjamin Gross, S Onur Sumer, Yichao Sun, Anders Jacobsen, Rileen Sinha, Erik Larsson,[...]. Sci Signal 2013
3

Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science.
Yuening Xiang, Zimu Guo, Pengfei Zhu, Jia Chen, Yongye Huang. Cancer Med 2019
233
3

Cytoscape: a software environment for integrated models of biomolecular interaction networks.
Paul Shannon, Andrew Markiel, Owen Ozier, Nitin S Baliga, Jonathan T Wang, Daniel Ramage, Nada Amin, Benno Schwikowski, Trey Ideker. Genome Res 2003
3

PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer.
HaiXia Li, JianFang Zeng, Keng Shen. Arch Gynecol Obstet 2014
139
3

The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer.
Seiji Mabuchi, Hiromasa Kuroda, Ryoko Takahashi, Tomoyuki Sasano. Gynecol Oncol 2015
281
3


Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy.
Devesh Tewari, Pooja Patni, Anusha Bishayee, Archana N Sah, Anupam Bishayee. Semin Cancer Biol 2022
103
3

KEGG: kyoto encyclopedia of genes and genomes.
M Kanehisa, S Goto. Nucleic Acids Res 2000
3

Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.
M Ashburner, C A Ball, J A Blake, D Botstein, H Butler, J M Cherry, A P Davis, K Dolinski, S S Dwight, J T Eppig,[...]. Nat Genet 2000
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.